clinofibrate has been researched along with Hyperlipoproteinemia Type II in 1 studies
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinofibrate was given to 15 patients with hyperlipidemia, for 6-8 weeks at the daily dose of 600 mg, and its effect on 3 biliary lipid components (cholesterol, bile acids and phospholipids) and on the lithogenic index was investigated." | 1.26 | Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia. ( Asano, T; Fujiyama, M; Ishikawa, K; Kajiyama, G; Kukita, H; Miki, H; Mishima, T; Murata, K; Takeuchi, N, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeuchi, N | 1 |
| Kukita, H | 1 |
| Kajiyama, G | 1 |
| Fujiyama, M | 1 |
| Ishikawa, K | 1 |
| Miki, H | 1 |
| Mishima, T | 1 |
| Murata, K | 1 |
| Asano, T | 1 |
1 other study available for clinofibrate and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholesterol; Female; Glycolates; Humans; Hyperlipidemias; H | 1982 |